EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Effect of Thymectomy on the Incidence of Extrathymic Cancers and Autoimmune Diseases in Patients With Non‐Thymomatous Myasthenia Gravis

Mohamed Khateb iD, Adnan Almasri, Carolina Barnett-Tapia, Vera Bril iD

Muscle & Nerve · 2026-06 · 73 (6) · 1065-1072

DOI: 10.1002/mus.70218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 20.03.2026. Verfasst von Mohamed Khateb und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Thymectomy, Myasthenia Gravis, Autoimmune Diseases, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Thymectomy is associated with positive effects on myasthenia gravis (MG), but there is conflicting evidence regarding potential deleterious long‐term outcomes, such as increased cancer and autoimmune disease risk. We aimed to assess these outcomes in thymectomized versus non‐thymectomized MG patients.

Methods

We retrospectively reviewed the medical records of patients with acquired, autoimmune MG followed at the Prosserman Neuromuscular Clinic, University Health Network (UHN), between January 2000 and July 2025. We excluded patients with malignancy or other autoimmune diseases before MG. We created matched datasets (thymectomy vs. no‐thymectomy) and built Cox models to assess the rate of new malignancy or autoimmune disease. We also used inverse probability of treatment weights (IPTW) to balance relevant covariates (age at MG onset, sex, disease duration, medications) in the full sample, and tested Cox models in the weighted dataset for each outcome.

Results

Of 566 patients, 106 had a thymoma and were excluded. Of the 460 patients included, 161 had a thymectomy. There was no difference in the hazard ratio (HR) for a new malignancy in the matched cohort (HR: 0.94, CI 0.83–1.07) nor in the IPTW model. The incidence of autoimmune disease was slightly higher in the thymectomy group in the matched cohort (HR 1.33 [1.15–1.52]), but there was no difference in the IPTW analyses (HR 1.55, CI [0.40–5.9]).

Discussion

In this cohort of patients with non‐thymomatous MG, thymectomy was not associated with an increased risk of malignancy. Different models for a second autoimmune disease had conflicting findings, requiring further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymectomyMyasthenia GravisAutoimmune DiseasesNeoplasmsHumansFemaleRetrospective StudiesIncidenceMaleMiddle AgedAdultAged

Stichwörter der Autor:innen

autoimmunecancermyasthenia gravisthymectomythymus

Autor:innen und Institutionen

  • Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Department of Internal Medicine, Yarmouk University, Yarmouk, Jordan.
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Mohamed Khateb, Vera Bril

Zitieren

APA

Khateb, M., Almasri, A., Barnett-Tapia, C., & Bril, V. (2026). The Effect of Thymectomy on the Incidence of Extrathymic Cancers and Autoimmune Diseases in Patients With Non‐Thymomatous Myasthenia Gravis. Muscle & Nerve, 73(6), 1065-1072. https://doi.org/10.1002/mus.70218

Vancouver

Khateb M, Almasri A, Barnett-Tapia C, Bril V. The Effect of Thymectomy on the Incidence of Extrathymic Cancers and Autoimmune Diseases in Patients With Non‐Thymomatous Myasthenia Gravis. Muscle & Nerve. 2026;73(6):1065-1072. doi:10.1002/mus.70218

BibTeX
@article{Khateb2026,
  author = {Khateb, Mohamed and Almasri, Adnan and Barnett-Tapia, Carolina and Bril, Vera},
  title = {The Effect of Thymectomy on the Incidence of Extrathymic Cancers and Autoimmune Diseases in Patients With Non‐Thymomatous Myasthenia Gravis},
  journal = {Muscle & Nerve},
  year = {2026},
  volume = {73},
  number = {6},
  pages = {1065--1072},
  doi = {10.1002/mus.70218}
}
Kostenlos starten →